FI860445A - Parvovirusvaccin foer hund. - Google Patents

Parvovirusvaccin foer hund. Download PDF

Info

Publication number
FI860445A
FI860445A FI860445A FI860445A FI860445A FI 860445 A FI860445 A FI 860445A FI 860445 A FI860445 A FI 860445A FI 860445 A FI860445 A FI 860445A FI 860445 A FI860445 A FI 860445A
Authority
FI
Finland
Prior art keywords
hund
vaccin
foer
parvovirus
pups
Prior art date
Application number
FI860445A
Other languages
English (en)
Other versions
FI85222B (fi
FI860445A0 (fi
FI85222C (fi
Inventor
Jill Welsh
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10573707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI860445(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI860445A0 publication Critical patent/FI860445A0/fi
Publication of FI860445A publication Critical patent/FI860445A/fi
Publication of FI85222B publication Critical patent/FI85222B/fi
Application granted granted Critical
Publication of FI85222C publication Critical patent/FI85222C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI860445A 1985-01-31 1986-01-30 Hund parvovirusstam och foerfarande foer framstaellning av ett hund parvovirusvaccin. FI85222C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502399A GB8502399D0 (en) 1985-01-31 1985-01-31 Canine parvovirus vaccines
GB8502399 1985-01-31

Publications (4)

Publication Number Publication Date
FI860445A0 FI860445A0 (fi) 1986-01-30
FI860445A true FI860445A (fi) 1986-08-01
FI85222B FI85222B (fi) 1991-12-13
FI85222C FI85222C (fi) 1992-03-25

Family

ID=10573707

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860445A FI85222C (fi) 1985-01-31 1986-01-30 Hund parvovirusstam och foerfarande foer framstaellning av ett hund parvovirusvaccin.

Country Status (16)

Country Link
US (2) US4810494A (fi)
EP (1) EP0189958B1 (fi)
JP (1) JPH07112982B2 (fi)
CN (1) CN1022801C (fi)
AT (1) ATE47524T1 (fi)
AU (1) AU592786B2 (fi)
CA (1) CA1278513C (fi)
DE (1) DE3666529D1 (fi)
DK (1) DK162421C (fi)
ES (1) ES8706030A1 (fi)
FI (1) FI85222C (fi)
GB (1) GB8502399D0 (fi)
IE (1) IE58357B1 (fi)
IL (1) IL77694A (fi)
NZ (1) NZ214984A (fi)
ZA (1) ZA86446B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines
ATE98680T1 (de) * 1987-09-28 1994-01-15 Beecham Inc Inaktivierung von viren und bakterien.
WO1991002054A1 (en) * 1989-08-08 1991-02-21 Arthur Webster Pty. Ltd. Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
AU633349B2 (en) * 1989-08-08 1993-01-28 Fort Dodge Australia Pty Limited Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
US5885585A (en) * 1994-11-08 1999-03-23 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US5814510A (en) * 1994-11-08 1998-09-29 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US6063385A (en) * 1997-11-07 2000-05-16 Wisconsin Alumni Research Foundation DNA vaccine for parvovirus
JP2006515024A (ja) * 2003-01-29 2006-05-18 ファイザー・プロダクツ・インク Ｂｏｒｄｅｔｅｌｌａｂｒｏｎｃｈｉｓｅｐｔｉｃａに対するイヌワクチン
US20050266027A1 (en) * 2004-05-25 2005-12-01 Watson James B Live organism product
US8802171B2 (en) * 2004-05-25 2014-08-12 James B. Watson Live organism product
US8052971B2 (en) * 2005-11-21 2011-11-08 MG Biologics Oral use of specific antibodies for intestinal health
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
NZ599585A (en) * 2007-06-14 2013-12-20 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
JP6200155B2 (ja) * 2010-03-05 2017-09-20 インターベット インターナショナル ベー． フェー． 組換え弱毒化パルボウイルス
CN101942419B (zh) * 2010-07-30 2012-08-22 中国农业科学院哈尔滨兽医研究所 犬细小病毒弱毒疫苗株及其应用
WO2012164372A1 (en) 2011-06-01 2012-12-06 Indian Immunologicals Limited Recombinant anti-canine parvovirus antibody and uses thereof
CN106591242B (zh) * 2016-11-18 2019-08-30 北京世纪元亨动物防疫技术有限公司 一株犬细小病毒毒株cpv-yh及其应用
CN109735505A (zh) * 2018-12-26 2019-05-10 河南农业大学 一株犬细小病毒毒株及其基因序列的扩增和应用
CN110859956B (zh) * 2019-11-07 2020-11-20 衡阳师范学院 一种犬细小病毒灭活疫苗及其制备方法
CN113073083B (zh) * 2020-01-03 2022-09-06 普莱柯生物工程股份有限公司 犬细小病毒弱毒株、及其制备的疫苗组合物和应用
CN117106732B (zh) * 2023-09-07 2024-02-06 华中农业大学 一株犬细小病毒及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193991A (en) * 1978-12-20 1980-03-18 Cornell Research Foundation, Inc. Canine parvovirus vaccine
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
EP0117767A1 (en) * 1983-01-07 1984-09-05 Mgi Pharma, Inc. Production of parvovirus subunit vaccines
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines

Also Published As

Publication number Publication date
DK162421C (da) 1992-03-23
JPS61180724A (ja) 1986-08-13
EP0189958A3 (en) 1988-07-06
DK47286A (da) 1986-08-01
ES8706030A1 (es) 1987-06-01
FI85222B (fi) 1991-12-13
JPH07112982B2 (ja) 1995-12-06
NZ214984A (en) 1988-05-30
ATE47524T1 (de) 1989-11-15
IL77694A (en) 1992-06-21
US4810494A (en) 1989-03-07
US5316764A (en) 1994-05-31
AU5280186A (en) 1986-08-07
IE860168L (en) 1986-07-31
FI860445A0 (fi) 1986-01-30
DK162421B (da) 1991-10-28
CN1022801C (zh) 1993-11-24
CA1278513C (en) 1991-01-02
AU592786B2 (en) 1990-01-25
EP0189958B1 (en) 1989-10-25
ZA86446B (en) 1986-09-24
FI85222C (fi) 1992-03-25
DE3666529D1 (en) 1989-11-30
IE58357B1 (en) 1993-09-08
GB8502399D0 (en) 1985-03-06
ES551461A0 (es) 1987-06-01
DK47286D0 (da) 1986-01-30
CN86100726A (zh) 1986-10-01
EP0189958A2 (en) 1986-08-06

Similar Documents

Publication Publication Date Title
FI860445A0 (fi) Parvovirusvaccin foer hund.
ES8500997A1 (es) Un metodo para producir un peptido.
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
CY1106635T1 (el) Ανοσοενισχυτικο που περιεχει ν - φορμυλο μεθειονυλο-πεπτιδια για εμβολια
ATE328068T1 (de) Papillomavirus vakzine
ATE178907T1 (de) Rezeptorbindende region des diphtherietoxius
FI941199A0 (fi) Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset
ATE214942T1 (de) Fibrinogen-bildungsprotein
DK0677114T3 (da) Rekombinant svinekoppevirus
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
EP0203676A3 (en) Vaccine for generating an immunogenic t cell response protective against a virus
ATE121780T1 (de) Neue bacillus thuringiensis-stämme, verfahren zu ihrer isolierung und verwandte insektizidzusammensetzungen.
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
ES2070846T3 (es) Arn-virus sin reversion.
ATE72400T1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
ATE356831T1 (de) Neuer galaninrezeptor
GR1000457B (el) Νεες ενωσεις.
DE69330246T2 (de) Impfstoffe auf der basis von streptokinase
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline
ATE126704T1 (de) Bcrf1-antagonisten zur behandlung von epstein- barr-virus-infektionen.
GR1000021B (el) Αντιπροσωπευτικο προιον ανοσιογενους ανασυνδυαζομενης ζυμης & μεθοδος καθαρισμου της.
GT198301987A (es) Formulaciones de interferon con estabilidad mejorada

Legal Events

Date Code Title Description
FG Patent granted

Owner name: AKZO N.V.

MA Patent expired